about
Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney diseaseClassification of chronic kidney disease in the elderly: pitfalls and errorsShould we use standard survival models or the illness-death model for interval-censored data to investigate risk factors of chronic kidney disease progression?Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis.A mild decrease of renal function is related to increased hemoglobin level during 5-year follow-up period.Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar.Effect of primary care physicians' use of estimated glomerular filtration rate on the timing of their subspecialty referral decisions.The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.Phosphate metabolism modulation in chronic kidney disease: when, how and to what extent?The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study.Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.Prevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective studyLow serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) StudyAutophagic clearance of mitochondria in the kidney copes with metabolic acidosis.Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care.Measuring total blood calcium displays a low sensitivity for the diagnosis of hypercalcemia in incident renal transplant recipients.Metabolic acidosis and the progression of chronic kidney disease.Advances in treatment of hyperkalemia in chronic kidney disease.Decrease in urinary creatinine excretion in early stage chronic kidney disease.Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: a cross-sectional studyPresence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled studyRe-evaluating the predictive roles of metabolic complications and clinical outcome according to eGFR levels--a four-years prospective cohort study in TaiwanHypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.Arterial remodeling associates with CKD progressionRenal function can improve at any stage of chronic kidney disease.Incident chronic kidney disease and newly developed complications related to renal dysfunction in an elderly population during 5 years: a community-based elderly population cohort study.A 3-marker index improves the identification of iron disorders in CKD anaemia.The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations.Measured GFR does not outperform estimated GFR in predicting CKD-related complicationsAge-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.Timing and determinants of erythropoietin deficiency in chronic kidney disease.Low Magnesium Exacerbates Osteoporosis in Chronic Kidney Disease Patients with Diabetes.Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.Prevalence and factors associated with hyperkalemia in predialysis patients followed in a low-clearance clinic.Prevalence of anemia in renal insufficiency among HIV infected patients initiating ART at a hospital in Northeast Ethiopia.Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
P2860
Q26863412-5494387A-AC17-446C-B5BE-884BB433811CQ27013799-401C4456-6208-4E13-BCD3-D8231B659B2BQ30877986-4FD77FE5-BB33-436D-A638-FD41553360ABQ30937496-262E6FB2-DCB1-4B6C-AA43-6E1BA457AF08Q33639624-0DD51954-461D-4E95-A4E9-94BEA44A48CCQ33721299-C8A22DD7-681F-424B-BA23-A291752F9446Q33793518-40690F81-CC97-417E-911A-221901D967E8Q33825492-1D178F48-DD4E-4260-9A71-A34C9504CAE2Q33877167-6BDCFC77-D027-4AD4-B1F5-C4ED5E3D21ACQ33932587-FF1C41DE-D859-4A70-B432-9A431A8E6CBAQ33944788-EE169997-BDBF-4D1D-B975-8DA433150EFBQ34021375-A226675D-C8D2-4878-BC99-7FC94B8889B8Q34124770-0817F6A0-25EA-485E-B4AA-6F79C6522A40Q34254449-62B8B327-FB72-4A0E-9814-BE1915746473Q34254623-292B7085-A91C-4CA7-AE74-9F15E7375EF1Q34260052-F41EC67C-B35E-4FCB-9342-A7DC000B3E42Q34367731-FE92E431-9BD9-40D6-8277-67533BCE5C6DQ34405366-8E6C6D71-4C93-4965-AD4A-B69915FED483Q34414019-10A18242-605A-403C-A120-7039FF4FBD58Q34491934-F9E41450-48FC-4F77-BAA1-E42287F24B08Q34523616-F05DE86A-86EC-4609-92B2-A283F95D3F1DQ34557041-E9C01EA3-3F41-4A86-840E-1D26CFD40AD0Q34650709-F805312C-6AD2-48A7-89DA-301F71D80D20Q34680658-C20C7243-85B7-48C7-96E9-1FF6791EDE7BQ34812460-767F49BF-0AA9-49A6-9D2E-429AF4F85318Q34870872-50EB5A5B-340E-4E8D-8D34-F8E19430468EQ35069799-EB38D5A6-9827-4272-8DBD-2489DD37C4F5Q35075773-63CBC288-7DCA-4FC9-A3F3-691E49AB3ECCQ35105827-9BBEEDEB-4E0B-46DE-8DF0-25CDAA34F8E9Q35227768-4FB4D7D7-90B1-4414-97B7-FE9513300374Q35272304-62A981C8-3C3F-4DA6-81F5-AF1EE1404316Q35664608-2E3B8F1A-E2D4-4987-9432-97011F3D7D02Q35682211-D28BF45E-F09C-4638-90CB-FB0BAB214D5AQ35692480-A6E8ACE3-2148-47AC-A1E1-CF2031274745Q35932324-4E580F2E-680C-499C-AFBF-928E451D06B1Q35985823-FBB720C3-F782-4E55-8C84-07E9AF9C18DBQ35992464-5C9FEEE8-85FA-46D5-A28A-6BCE7A6F81FDQ36126918-1F0F8969-093F-4F57-9C7C-5928F17B9DE7Q36258268-75C57209-2382-4368-880E-25AE259E6256Q36390782-C797E597-2755-4813-B652-33EAB246F842
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Timing of onset of CKD-related metabolic complications
@en
Timing of onset of CKD-related metabolic complications.
@nl
type
label
Timing of onset of CKD-related metabolic complications
@en
Timing of onset of CKD-related metabolic complications.
@nl
prefLabel
Timing of onset of CKD-related metabolic complications
@en
Timing of onset of CKD-related metabolic complications.
@nl
P2093
P2860
P50
P356
P1476
Timing of onset of CKD-related metabolic complications
@en
P2093
Bruno Fouqueray
Cedric Gauci
Christian Jacquot
Jean Philippe Haymann
Jean-Jacques Boffa
Jerome Rossert
Mona Ben M'rad
NephroTest Study Group
Pascal Houillier
P2860
P304
P356
10.1681/ASN.2008020159
P577
2008-11-12T00:00:00Z